Detalhe da pesquisa
1.
Alternative splicing in prostate cancer progression and therapeutic resistance.
Oncogene
; 43(22): 1655-1668, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658776
2.
Discovery and Characterization of Selective, First-in-Class Inhibitors of Citron Kinase.
J Med Chem
; 67(4): 2631-2666, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330278
3.
Androgen-responsive serum response factor target genes regulate prostate cancer cell migration.
Carcinogenesis
; 34(8): 1737-46, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23576568
4.
The association between calcium channel blocker use and prostate cancer outcome.
Prostate
; 73(8): 865-72, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23280547
5.
Deregulated kinase action in prostate cancer: molecular basis and therapeutic implications.
Endocr Relat Cancer
; 30(9)2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279256
6.
Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase.
Cancer Res
; 83(24): 4142-4160, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801613
7.
Analyzing the Androgen Receptor Interactome in Prostate Cancer: Implications for Therapeutic Intervention.
Cells
; 11(6)2022 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35326387
8.
PAM50 and Beyond: When Will Tissue Transcriptomics Guide Clinical Decision-making?
Eur Urol Focus
; 8(4): 916-918, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031559
9.
Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex.
Endocr Rev
; 28(7): 778-808, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17940184
10.
Somatic Alterations Impact AR Transcriptional Activity and Efficacy of AR-Targeting Therapies in Prostate Cancer.
Cancers (Basel)
; 13(16)2021 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34439101
11.
Novel insights in cell cycle dysregulation during prostate cancer progression.
Endocr Relat Cancer
; 28(6): R141-R155, 2021 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33830069
12.
Genomic alterations impact cell cycle-related genes during prostate cancer progression.
Endocr Relat Cancer
; 28(6): L5-L10, 2021 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852421
13.
Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells.
Prostate
; 70(9): 959-70, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20166126
14.
Androgen modulation of coregulator expression in prostate cancer cells.
Mol Endocrinol
; 23(4): 572-83, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19164447
15.
Androgen receptor co-regulation in prostate cancer.
Asian J Urol
; 7(3): 219-232, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32742924
16.
AR-dependent phosphorylation and phospho-proteome targets in prostate cancer.
Endocr Relat Cancer
; 27(6): R193-R210, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32276264
17.
Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular Subtypes.
Eur Urol Open Sci
; 22: 34-44, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33299986
18.
Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.
Endocr Relat Cancer
; 16(1): 123-37, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18845648
19.
Androgen deprivation increases p300 expression in prostate cancer cells.
Cancer Res
; 67(7): 3422-30, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17409453
20.
Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy.
Oncogene
; 38(23): 4496-4511, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30742064